0,949  0,002  Monophenol monooxygenase inhibitor
0,948  0,001  NOS2 expression inhibitor
0,941  0,002  Chemopreventive
0,936  0,003  Lipoxygenase inhibitor
0,873  0,008  Transcription factor NF kappa B inhibitor
0,853  0,002  Melanin inhibitor
0,852  0,005  15-Lipoxygenase inhibitor
0,830  0,013  Apoptosis agonist
0,813  0,007  Antineoplastic (lung cancer)
0,797  0,004  CYP1A2 inhibitor
0,795  0,016  Antiinflammatory
0,766  0,003  Skin whitener
0,744  0,005  Antioxidant
0,741  0,005  Proliferative diseases treatment
0,739  0,004  Hypoxia-inducible factor 1 alpha inhibitor
0,738  0,015  Antineoplastic (breast cancer)
0,720  0,005  AR expression inhibitor
0,715  0,005  Antiprotozoal (Leishmania)
0,715  0,005  Free radical scavenger
0,710  0,012  Antileukemic
0,695  0,007  UGT1A9 substrate
0,661  0,007  Nitric oxide antagonist
0,656  0,005  Antineoplastic (glioma)
0,665  0,017  Antineoplastic (colorectal cancer)
0,659  0,017  Antineoplastic (colon cancer)
0,650  0,012  Antineoplastic (ovarian cancer)
0,631  0,010  Spasmolytic
0,627  0,007  Antineoplastic (brain cancer)
0,622  0,011  Antineoplastic (melanoma)
0,609  0,016  Antihypercholesterolemic
0,594  0,014  Antineoplastic (cervical cancer)
0,589  0,011  Cardioprotectant
0,599  0,023  Alzheimer's disease treatment
0,574  0,004  NOS3 expression enhancer
0,566  0,010  Hypoglycemic
0,561  0,014  NOS3 expression inhibitor
0,554  0,008  Antineoplastic (glioblastoma multiforme)
0,570  0,024  Antibacterial
0,558  0,014  Antiosteoporotic
0,558  0,015  Hepatic disorders treatment
0,542  0,004  Protein-tyrosine phosphatase 1B inhibitor
0,543  0,009  Vasodilator
0,545  0,020  Bone diseases treatment
0,546  0,025  Prostate cancer treatment
0,521  0,005  Protein-tyrosine phosphatase inhibitor
0,519  0,005  Lipid peroxidase inhibitor
0,513  0,003  Electron transport complex I inhibitor
0,546  0,039  Cyclophilin D inhibitor
0,546  0,039  Antidiabetic
0,511  0,009  Myocardial infarction treatment
0,506  0,005  Antihypotensive
0,517  0,019  Cytostatic
0,504  0,010  UGT1A1 substrate
0,505  0,019  Caspase 3 stimulant
0,507  0,022  Chemoprotective
0,499  0,021  12-Lipoxygenase inhibitor
0,493  0,023  Radioprotector
0,465  0,004  Heat shock protein 90 antagonist
0,482  0,027  Cytotoxic
0,475  0,031  CYP2C19 inhibitor
0,462  0,018  Antiparasitic
0,455  0,012  Antihelmintic
0,500  0,059  Caspase 9 stimulant
0,449  0,009  Antineoplastic (squamous cell carcinoma)
0,463  0,022  Antineoplastic (multiple myeloma)
0,446  0,008  Platelet adhesion inhibitor
0,478  0,042  Antiprotozoal
0,452  0,017  Antidiabetic symptomatic
0,449  0,018  UGT1A6 substrate
0,447  0,024  Antineoplastic (non-small cell lung cancer)
0,437  0,017  Antihypertriglyceridemic
0,462  0,044  Immunosuppressant
0,428  0,017  UDP-glucuronosyltransferase substrate
0,419  0,016  Antineoplastic (lymphocytic leukemia)
0,409  0,012  Hepatoprotectant
0,409  0,018  Antiulcerative
0,421  0,033  Apoptosis antagonist
0,402  0,023  Antineoplastic (renal cancer)
0,435  0,057  Histamine release inhibitor
0,407  0,030  Antidiabetic (type 2)
0,397  0,029  Antiamyloidogenic
0,372  0,006  5-Lipoxygenase inhibitor
0,364  0,003  Papain-like protease (SARS coronavirus) inhibitor
0,385  0,024  Vascular (periferal) disease treatment
0,388  0,030  Antiprotozoal (Trypanosoma)
0,359  0,008  Heat shock protein 90 alpha antagonist
0,393  0,043  ICAM1 expression inhibitor
0,389  0,041  Lipoprotein disorders treatment
0,354  0,009  Neurotrophic factor enhancer
0,386  0,051  Streptokinase A inhibitor
0,361  0,030  Transcription factor STAT inhibitor
0,344  0,014  Topoisomerase II inhibitor
0,430  0,102  Alpha-glucosidase inhibitor
0,339  0,015  Tubulin antagonist
0,339  0,016  UGT1A3 substrate
0,393  0,081  Antiparkinsonian
0,345  0,034  Transcription factor STAT3 inhibitor
0,379  0,068  CYP3A4 substrate
0,328  0,018  Antineoplastic (carcinoma)
0,322  0,015  Genotoxic
0,344  0,042  Antipyretic
0,302  0,005  Estrogen receptor alpha antagonist
0,355  0,059  Antifungal
0,367  0,079  Antiobesity
0,293  0,007  Dementia treatment
0,290  0,007  Vascular dementia treatment
0,288  0,005  Aromatase inhibitor
0,320  0,039  Antimitotic
0,327  0,052  Antineoplastic (osteosarcoma)
0,328  0,058  Antineoplastic (pancreatic cancer)
0,278  0,010  Antihemorrhagic
0,343  0,075  Antiprotozoal (Plasmodium)
0,317  0,051  DNA damaging
0,322  0,066  Respiratory analeptic
0,341  0,087  Ulceration
0,255  0,004  Ornithine decarboxylase inhibitor
0,294  0,044  Antineoplastic (sarcoma)
0,288  0,039  Antineoplastic enhancer
0,317  0,069  Antimycobacterial
0,253  0,008  Beta amyloid protein antagonist
0,293  0,052  Antineoplastic (lymphoma)
0,305  0,073  Antiischemic
0,234  0,005  Lipase inhibitor
0,285  0,058  Platelet antagonist
0,284  0,058  Antineoplastic (liver cancer)
0,295  0,069  CYP2C19 substrate
0,237  0,014  Antibacterial (Helicobacter pylori)
0,272  0,051  Carcinogenic
0,255  0,041  Non-steroidal antiinflammatory agent
0,241  0,029  UGT2B15 substrate
0,325  0,114  TNF expression inhibitor
0,215  0,011  Estrogen antagonist
0,252  0,048  RNA-directed DNA polymerase inhibitor
0,244  0,043  P-glycoprotein inhibitor
0,293  0,093  Vasodilator, coronary
0,209  0,010  Phosphodiesterase 4D inhibitor
0,291  0,097  Angiogenesis inhibitor
0,256  0,064  Hypolipemic
0,303  0,114  CYP2C9 inhibitor
0,265  0,082  Antituberculosic
0,193  0,010  Actinic keratosis treatment
0,211  0,030  Acetylcholinesterase inhibitor
0,194  0,014  Gastritis treatment
0,187  0,011  Estrogen receptor beta antagonist
0,221  0,049  Diabetic retinopathy treatment
0,202  0,033  Cyclooxygenase 1 inhibitor
0,177  0,009  Estrogen agonist
0,172  0,005  Neuraminidase inhibitor
0,184  0,017  Topoisomerase II alpha inhibitor
0,190  0,025  Farnesoid X receptor antagonist
0,214  0,049  Antimutagenic
0,201  0,040  MAO inhibitor
0,169  0,010  Postmenopausal disorders treatment
0,187  0,030  Topoisomerase I inhibitor
0,159  0,004  Potassium channel Kv1.3 blocker
0,232  0,078  Angiogenesis stimulant
0,176  0,025  Antineoplastic antibiotic
0,258  0,109  CYP3A4 inhibitor
0,273  0,129  CYP2C9 substrate
0,148  0,005  Ca(v)3.1 blocker
0,186  0,043  Antidiarrheal
0,160  0,019  Urease inhibitor
0,225  0,088  Cardiovascular analeptic
0,186  0,050  Antiviral (Influenza A)
0,154  0,025  Gastric antisecretory
0,172  0,043  Neurotrophic factor
0,190  0,063  UGT1A4 substrate
0,130  0,010  Neuraminidase (influenza) inhibitor
0,235  0,114  Analeptic
0,129  0,009  Estrogen receptor beta agonist
0,207  0,087  Antiviral (HIV)
0,202  0,085  VCAM1 expression inhibitor
0,175  0,059  Cholinergic
0,222  0,108  Huntington's disease treatment
0,193  0,081  Sensitization
0,167  0,057  Protein kinase stimulant
0,154  0,047  DNA polymerase I inhibitor
0,111  0,004  Transcription factor RelA inhibitor
0,132  0,027  Antiviral (Coronavirus)
0,132  0,027  Antiviral (SARS coronavirus)
0,179  0,075  Mutagenic
0,182  0,081  Sedative
0,156  0,055  Bone formation stimulant
0,294  0,193  Antineoplastic (solid tumors)
0,123  0,029  Carbonic anhydrase XIII inhibitor
0,160  0,066  Interferon gamma antagonist
0,139  0,051  Cholesterol synthesis inhibitor
0,122  0,038  Breast cancer-resistant protein inhibitor
0,151  0,069  Cyclooxygenase inhibitor
0,123  0,043  Bronchodilator
0,145  0,067  Antifungal (Cryptococcus)
0,108  0,033  Bile acid receptor antagonist
0,196  0,122  Superoxide dismutase inhibitor
0,100  0,028  Peroxisome proliferator-activated receptor gamma agonist
0,096  0,023  Phosphodiesterase VI inhibitor
0,168  0,097  Antiviral (Influenza)
0,101  0,031  Na+ K+ transporting ATPase inhibitor
0,077  0,008  Retinoid X receptor agonist
0,103  0,036  NAD(P)H dehydrogenase (quinone) inhibitor
0,178  0,113  Antiglaucomic
0,117  0,052  MAO B inhibitor
0,088  0,027  Leukotriene antagonist
0,105  0,045  ABCA1 expression enhancer
0,112  0,052  Butyrylcholinesterase inhibitor
0,066  0,007  Retinoic acid alpha receptor agonist
0,131  0,072  Antiacne
0,085  0,027  Beta tubulin antagonist
0,199  0,142  UGT2B4 substrate
0,160  0,106  Sepsis treatment
0,068  0,016  Vanilloid 2 antagonist
0,083  0,032  HIV-1 integrase (3'-Processing) inhibitor
0,154  0,105  Amyloid beta aggregation inhibitor
0,152  0,103  Diabetic nephropathy treatment
0,209  0,160  CTGF expression inhibitor
0,066  0,019  Glucose-6-phosphate translocase inhibitor
0,066  0,019  Pregnane X receptor antagonist
0,138  0,096  UGT2B7 substrate
0,141  0,099  Arachidonic acid antagonist
0,134  0,093  Antiviral (Herpes)
0,226  0,185  Antineoplastic (small cell lung cancer)
0,119  0,080  Cyclooxygenase 2 inhibitor
0,126  0,087  Psychosexual dysfunction treatment
0,091  0,053  Phosphodiesterase IV inhibitor
0,133  0,096  Thrombolytic
0,157  0,120  CYP2B6 inhibitor
0,134  0,097  UGT2B9 substrate
0,148  0,114  LDLR expression enhancer
0,107  0,075  TRPA1 agonist
0,032  0,005  Retinoic acid alpha receptor antagonist
0,065  0,038  HIV-1 integrase (Strand Transfer) inhibitor
0,098  0,072  Beta glucuronidase inhibitor
0,091  0,067  Alpha 2d adrenoreceptor antagonist
0,111  0,087  Contraceptive female
0,057  0,034  Aldose reductase inhibitor
0,084  0,061  Androgen antagonist
0,043  0,020  Retinoid X receptor antagonist
0,046  0,025  Cathepsin L2 inhibitor
0,030  0,009  Inosine monophosphate dehydrogenase 1 inhibitor
0,195  0,175  Antihypertensive
0,071  0,052  Peroxisome proliferator-activated receptor gamma antagonist
0,075  0,056  Keratolytic
0,151  0,137  Histone acetyltransferase inhibitor
0,028  0,014  Toll-Like receptor 4 agonist
0,023  0,009  Retinoic acid receptor antagonist
0,141  0,129  Succinate dehydrogenase inhibitor
0,104  0,093  Amylase inhibitor
0,084  0,074  SULT1E1 substrate
0,073  0,063  Antitreponemal
0,051  0,043  Leukotriene B4 antagonist
0,033  0,026  Retinoid X alpha receptor agonist
0,023  0,016  Retinoic acid receptor agonist
0,213  0,208  Antipruritic, allergic
0,032  0,029  Retinoid X alpha receptor antagonist
0,020  0,018  Leukotriene B4 receptor 2 antagonist
0,105  0,103  Coagulant
0,104  0,102  Alcohol dehydrogenase substrate
0,027  0,027  Liver X receptor antagonist

